Longitudinal analysis of ocular disease in children with Mucopolysaccharidosis I after hematopoietic cell transplantation.
暂无分享,去创建一个
J. van Doorn | P. V. van Hasselt | J. Boelens | B. T. A. van den Broek | J. Achterberg | H. Prinsen | Michelle B. van Egmond-Ebbeling | Isa C Vlessert
[1] D. Mutti,et al. Ocular Component Development during Infancy and Early Childhood. , 2018, Optometry and vision science : official publication of the American Academy of Optometry.
[2] E. Chen,et al. Children with mucopolysaccharidosis risk progressive visual dysfunction despite haematopoietic stem cell transplants , 2018, Acta paediatrica.
[3] J. van Doorn,et al. Salivary α-Iduronidase Activity as a Potential New Biomarker for the Diagnosis and Monitoring the Effect of Therapy in Mucopolysaccharidosis Type I. , 2018, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[4] T. Aslam,et al. The effect of haemopoietic stem cell transplantation on the ocular phenotype in mucopolysaccharidosis type I (Hurler) , 2018, Acta ophthalmologica.
[5] J. Eisengart,et al. Long-term outcomes of systemic therapies for Hurler syndrome: an international multi-center comparison , 2018, Genetics in Medicine.
[6] P. Veys,et al. Quality of life of Hurler syndrome patients after successful hematopoietic stem cell transplantation. , 2017, Blood advances.
[7] P. Szodoray,et al. Evaluation of commonly used tear sampling methods and their relevance in subsequent biochemical analysis , 2017, Annals of clinical biochemistry.
[8] T. Aslam,et al. Objective Quantification of Changes in Corneal Clouding Over Time in Patients With Mucopolysaccharidosis. , 2017, Investigative ophthalmology & visual science.
[9] V. Lee,et al. Allogeneic Hematopoietic Stem Cell Transplantation in Thirty-Four Pediatric Cases of Mucopolysaccharidosis-A Ten-Year Report from the China Children Transplant Group. , 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[10] C. Summers,et al. Outcomes of keratoplasty in the mucopolysaccharidoses: an international perspective , 2016, British Journal of Ophthalmology.
[11] J. Tolar,et al. A novel explanation of corneal clouding in a bone marrow transplant-treated patient with Hurler syndrome. , 2016, Experimental eye research.
[12] J. Kurtzberg,et al. AAV Gene Therapy for MPS1-associated Corneal Blindness , 2016, Scientific Reports.
[13] H. van Lenthe,et al. A Multiplex Assay for the Diagnosis of Mucopolysaccharidoses and Mucolipidoses , 2015, PloS one.
[14] A. T. van der Ploeg,et al. Hematopoietic cell transplantation for mucopolysaccharidosis patients is safe and effective: results after implementation of international guidelines. , 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[15] A. Fischer,et al. Long-term outcome of Hurler syndrome patients after hematopoietic cell transplantation: an international multicenter study. , 2015, Blood.
[16] A. Fischer,et al. Outcomes of transplantation using various hematopoietic cell sources in children with Hurler syndrome after myeloablative conditioning. , 2013, Blood.
[17] C. Summers,et al. Clinical guidelines for diagnosing and managing ocular manifestations in children with mucopolysaccharidosis , 2012, Acta ophthalmologica.
[18] E. Chen,et al. Corneal hysteresis in mucopolysaccharidosis I and VI , 2012, Acta ophthalmologica.
[19] B. Pierscionek,et al. Age variations in intraocular pressure in a cohort of healthy Austrian school children , 2012, Eye.
[20] M. Repka,et al. Central corneal thickness in children. , 2011, Archives of ophthalmology.
[21] L. el Matri,et al. Pediatric penetrating keratoplasty: indications and outcomes. , 2011, Transplantation proceedings.
[22] C. Summers,et al. Systemic therapies for mucopolysaccharidosis: ocular changes following haematopoietic stem cell transplantation or enzyme replacement therapy – a review , 2010 .
[23] O. Oner,et al. Central corneal thickness in children with diabetes. , 2009, Journal of refractive surgery.
[24] J. Kurtzberg,et al. Risk factor analysis of outcomes after unrelated cord blood transplantation in patients with hurler syndrome. , 2009, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[25] S. Biswas,et al. Mucopolysaccharidoses and the eye. , 2006, Survey of ophthalmology.
[26] N. Chamoles,et al. Hurler-like phenotype: enzymatic diagnosis in dried blood spots on filter paper. , 2001, Clinical chemistry.
[27] R. Hansen,et al. Cycloplegic refractions in healthy children aged 1 through 48 months. , 2001, Archives of ophthalmology.
[28] W. Petroll,et al. Corneal stromal wound healing in refractive surgery: the role of myofibroblasts , 1999, Progress in Retinal and Eye Research.
[29] J. Koretz,et al. The development and maintenance of emmetropia , 1999, Eye.
[30] C. Summers,et al. Ocular abnormalities in the mucopolysaccharidoses after bone marrow transplantation. Longer follow-up. , 1998, Ophthalmology.
[31] T. Møller-Pedersen,et al. Confocal microscopic characterization of wound repair after photorefractive keratectomy. , 1998, Investigative ophthalmology & visual science.
[32] A. Vellodi,et al. Ultrastructural study of the cornea in a bone marrow-transplanted Hurler syndrome patient. , 1996, Experimental eye research.
[33] J. Hassell,et al. Regulation of corneal collagen fibrillogenesis in vitro by corneal proteoglycan (lumican and decorin) core proteins. , 1993, Experimental eye research.
[34] G. Constantopoulos,et al. Corneal opacity in canine MPS I. Changes after bone marrow transplantation. , 1989, Investigative ophthalmology & visual science.
[35] M S Borcherding,et al. Proteoglycans and collagen fibre organization in human corneoscleral tissue. , 1975, Experimental eye research.